FELIX BAKER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FELIX BAKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FELIX BAKER. FELIX BAKER is Director in ALEXION PHARMACEUTICALS INC ($ALXN) and in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX).
Latest Insider Trading Transactions of FELIX BAKER
Sentiment: All, ALXN, GHDX, SGEN, GEVA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.50 | 8,627 | 271,712 | 38,440,212 | 38.4 M to 38.4 M (+0.02 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.50 | 940 | 29,606 | 4,458,907 | 4.5 M to 4.5 M (+0.02 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.89 | 273,381 | 8,719,077 | 38,431,585 | 38.2 M to 38.4 M (+0.72 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.89 | 29,772 | 949,533 | 4,457,967 | 4.4 M to 4.5 M (+0.67 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.74 | 145,272 | 4,611,296 | 38,158,204 | 38 M to 38.2 M (+0.38 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.74 | 15,821 | 502,198 | 4,428,195 | 4.4 M to 4.4 M (+0.36 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.50 | 63,560 | 2,002,401 | 38,012,932 | 37.9 M to 38 M (+0.17 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.50 | 6,922 | 218,071 | 4,412,374 | 4.4 M to 4.4 M (+0.16 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.31 | 387,336 | 12,514,051 | 37,949,372 | 37.6 M to 37.9 M (+1.03 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.31 | 42,182 | 1,362,816 | 4,405,452 | 4.4 M to 4.4 M (+0.97 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 33.77 | 107,260 | 3,622,063 | 37,562,036 | 37.5 M to 37.6 M (+0.29 %) |
| Mar 16 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 33.77 | 11,681 | 394,456 | 4,363,270 | 4.4 M to 4.4 M (+0.27 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.34 | 4,874 | 157,646 | 37,454,776 | 37.4 M to 37.5 M (+0.01 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.34 | 547 | 17,692 | 4,351,589 | 4.4 M to 4.4 M (+0.01 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 33.15 | 147,831 | 4,900,997 | 37,449,902 | 37.3 M to 37.4 M (+0.40 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 33.15 | 16,608 | 550,600 | 4,351,042 | 4.3 M to 4.4 M (+0.38 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.96 | 23,289 | 767,582 | 37,302,071 | 37.3 M to 37.3 M (+0.06 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.96 | 2,616 | 86,221 | 4,334,434 | 4.3 M to 4.3 M (+0.06 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.41 | 95,682 | 3,100,652 | 37,278,782 | 37.2 M to 37.3 M (+0.26 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.41 | 10,749 | 348,330 | 4,331,818 | 4.3 M to 4.3 M (+0.25 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.30 | 165,237 | 5,337,915 | 37,183,100 | 37 M to 37.2 M (+0.45 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.30 | 18,563 | 599,670 | 4,321,069 | 4.3 M to 4.3 M (+0.43 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.15 | 36,589 | 1,139,842 | 37,017,863 | 37 M to 37 M (+0.10 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.15 | 4,111 | 128,068 | 4,302,506 | 4.3 M to 4.3 M (+0.10 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.12 | 97,272 | 3,124,484 | 36,981,274 | 36.9 M to 37 M (+0.26 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.12 | 10,927 | 350,987 | 4,298,395 | 4.3 M to 4.3 M (+0.25 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.47 | 53,734 | 1,744,598 | 36,884,002 | 36.8 M to 36.9 M (+0.15 %) |
| Mar 11 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.47 | 6,037 | 196,005 | 4,287,468 | 4.3 M to 4.3 M (+0.14 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Option Exercise | M | 4.18 | 10,000 | 41,800 | 0 | |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Option Exercise | M | 4.18 | 10,000 | 41,800 | 0 | |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 0.00 | 88,732 | 0 | 36,830,268 | 36.7 M to 36.8 M (+0.24 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 0.00 | 9,968 | 0 | 4,281,431 | 4.3 M to 4.3 M (+0.23 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 0.00 | 48,996 | 0 | 36,741,536 | 36.7 M to 36.7 M (+0.13 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 0.00 | 5,504 | 0 | 4,271,463 | 4.3 M to 4.3 M (+0.13 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | M | 4.18 | 10,000 | 41,800 | 36,692,540 | 36.7 M to 36.7 M (+0.03 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | M | 4.18 | 10,000 | 41,800 | 4,265,959 | 4.3 M to 4.3 M (+0.23 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 33.73 | 14,157 | 477,445 | 36,682,540 | 36.7 M to 36.7 M (+0.04 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 33.73 | 1,590 | 53,623 | 4,255,959 | 4.3 M to 4.3 M (+0.04 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 33.68 | 40,921 | 1,378,043 | 36,668,383 | 36.6 M to 36.7 M (+0.11 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 33.68 | 4,597 | 154,807 | 4,254,369 | 4.2 M to 4.3 M (+0.11 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.49 | 218,550 | 7,101,280 | 36,627,462 | 36.4 M to 36.6 M (+0.60 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.49 | 23,908 | 776,835 | 4,249,772 | 4.2 M to 4.2 M (+0.57 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.68 | 41,104 | 1,302,257 | 36,408,912 | 36.4 M to 36.4 M (+0.11 %) |
| Mar 08 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.68 | 4,496 | 142,442 | 4,225,864 | 4.2 M to 4.2 M (+0.11 %) |
| Mar 02 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.24 | 59,492 | 1,918,022 | 36,367,808 | 36.3 M to 36.4 M (+0.16 %) |
| Mar 02 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.24 | 6,508 | 209,818 | 4,221,368 | 4.2 M to 4.2 M (+0.15 %) |
| Mar 02 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.76 | 301,066 | 9,862,139 | 36,308,316 | 36 M to 36.3 M (+0.84 %) |
| Mar 02 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 32.76 | 32,934 | 1,078,832 | 4,214,860 | 4.2 M to 4.2 M (+0.79 %) |
| Mar 02 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.24 | 21,814 | 681,563 | 36,007,250 | 36 M to 36 M (+0.06 %) |
| Mar 02 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.24 | 2,386 | 74,549 | 4,181,926 | 4.2 M to 4.2 M (+0.06 %) |
| Mar 02 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 30.34 | 172,462 | 5,232,928 | 35,985,436 | 35.8 M to 36 M (+0.48 %) |
| Mar 02 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 30.34 | 18,866 | 572,442 | 4,179,540 | 4.2 M to 4.2 M (+0.45 %) |
| Mar 02 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 30.55 | 54,439 | 1,663,024 | 35,812,974 | 35.8 M to 35.8 M (+0.15 %) |
| Mar 02 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 30.55 | 5,955 | 181,916 | 4,160,674 | 4.2 M to 4.2 M (+0.14 %) |
| Feb 26 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 30.13 | 39,815 | 1,199,793 | 35,758,535 | 35.7 M to 35.8 M (+0.11 %) |
| Feb 26 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 30.13 | 4,485 | 135,152 | 4,154,719 | 4.2 M to 4.2 M (+0.11 %) |
| Feb 26 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.86 | 128,255 | 3,830,118 | 35,718,720 | 35.6 M to 35.7 M (+0.36 %) |
| Feb 26 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.86 | 14,447 | 431,435 | 4,150,234 | 4.1 M to 4.2 M (+0.35 %) |
| Feb 26 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 28.52 | 67,407 | 1,922,670 | 35,590,465 | 35.5 M to 35.6 M (+0.19 %) |
| Feb 26 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 28.52 | 7,593 | 216,577 | 4,135,787 | 4.1 M to 4.1 M (+0.18 %) |
| Feb 26 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 28.47 | 4,134 | 117,674 | 35,523,058 | 35.5 M to 35.5 M (+0.01 %) |
| Feb 26 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 28.47 | 466 | 13,265 | 4,128,194 | 4.1 M to 4.1 M (+0.01 %) |
| Feb 26 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.77 | 43,056 | 1,281,975 | 35,518,924 | 35.5 M to 35.5 M (+0.12 %) |
| Feb 26 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.77 | 4,850 | 144,407 | 4,127,728 | 4.1 M to 4.1 M (+0.12 %) |
| Feb 22 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 30.21 | 218,768 | 6,610,053 | 35,475,868 | 35.3 M to 35.5 M (+0.62 %) |
| Feb 22 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 30.21 | 24,643 | 744,586 | 4,122,878 | 4.1 M to 4.1 M (+0.60 %) |
| Feb 22 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.20 | 456,849 | 13,339,991 | 35,257,100 | 34.8 M to 35.3 M (+1.31 %) |
| Feb 22 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.20 | 49,677 | 1,450,568 | 4,098,235 | 4 M to 4.1 M (+1.23 %) |
| Feb 22 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.94 | 226,865 | 6,791,816 | 34,800,251 | 34.6 M to 34.8 M (+0.66 %) |
| Feb 22 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.94 | 24,669 | 738,533 | 4,048,558 | 4 M to 4 M (+0.61 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.25 | 726,291 | 22,694,197 | 34,573,386 | 33.8 M to 34.6 M (+2.15 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 31.25 | 78,976 | 2,467,739 | 4,023,889 | 3.9 M to 4 M (+2.00 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.50 | 902 | 26,609 | 33,847,095 | 33.8 M to 33.8 M (0.00 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.50 | 98 | 2,891 | 3,944,913 | 3.9 M to 3.9 M (0.00 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.19 | 106,444 | 3,107,590 | 33,846,193 | 33.7 M to 33.8 M (+0.32 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 29.19 | 11,575 | 337,927 | 3,944,815 | 3.9 M to 3.9 M (+0.29 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 30.27 | 151,144 | 4,574,645 | 33,739,749 | 33.6 M to 33.7 M (+0.45 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 30.27 | 16,435 | 497,435 | 3,933,240 | 3.9 M to 3.9 M (+0.42 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 27.93 | 631 | 17,626 | 33,588,605 | 33.6 M to 33.6 M (0.00 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 27.93 | 69 | 1,927 | 3,916,805 | 3.9 M to 3.9 M (0.00 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 27.28 | 72,073 | 1,966,043 | 33,587,974 | 33.5 M to 33.6 M (+0.22 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 27.28 | 7,909 | 215,746 | 3,916,736 | 3.9 M to 3.9 M (+0.20 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 28.07 | 87,049 | 2,443,831 | 33,515,901 | 33.4 M to 33.5 M (+0.26 %) |
| Feb 17 2016 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 28.07 | 9,551 | 268,137 | 3,908,827 | 3.9 M to 3.9 M (+0.24 %) |
| Jan 05 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 35.20 | 568 | 19,994 | 308,843 | 308.3 K to 308.8 K (+0.18 %) |
| Jan 05 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 35.20 | 568 | 19,994 | 11,249,282 | 11.2 M to 11.2 M (+0.01 %) |
| Jan 05 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 35.20 | 568 | 19,994 | 1,738,405 | 1.7 M to 1.7 M (+0.03 %) |
| Jan 05 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 35.20 | 568 | 19,994 | 22,235 | 21.7 K to 22.2 K (+2.62 %) |
| Jan 05 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 35.20 | 568 | 19,994 | 182,894 | 182.3 K to 182.9 K (+0.31 %) |
| Jan 05 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 35.20 | 568 | 19,994 | 203,158 | 202.6 K to 203.2 K (+0.28 %) |
| Nov 20 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 44.00 | 150,000 | 6,600,000 | 33,428,852 | 33.3 M to 33.4 M (+0.45 %) |
| Nov 20 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 43.87 | 31,647 | 1,388,259 | 33,278,852 | 33.2 M to 33.3 M (+0.10 %) |
| Nov 20 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 43.93 | 57,461 | 2,524,015 | 33,247,205 | 33.2 M to 33.2 M (+0.17 %) |
| Nov 20 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 43.93 | 75,612 | 3,321,363 | 33,189,744 | 33.1 M to 33.2 M (+0.23 %) |
| Nov 20 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 43.00 | 4,000 | 172,000 | 33,114,132 | 33.1 M to 33.1 M (+0.01 %) |
| Nov 20 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 43.84 | 10,638 | 466,321 | 33,110,132 | 33.1 M to 33.1 M (+0.03 %) |
| Nov 10 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 44.00 | 9,400 | 413,600 | 33,099,494 | 33.1 M to 33.1 M (+0.03 %) |
| Nov 10 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 43.00 | 800 | 34,400 | 33,090,094 | 33.1 M to 33.1 M (0.00 %) |
| Nov 10 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 43.71 | 407,800 | 17,823,388 | 33,089,294 | 32.7 M to 33.1 M (+1.25 %) |
| Nov 10 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 44.00 | 98,700 | 4,342,800 | 32,681,494 | 32.6 M to 32.7 M (+0.30 %) |
| Nov 10 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 41.31 | 196,490 | 8,117,179 | 32,582,794 | 32.4 M to 32.6 M (+0.61 %) |
| Nov 10 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 42.51 | 221,434 | 9,412,318 | 32,386,304 | 32.2 M to 32.4 M (+0.69 %) |
| Oct 05 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 21.34 | 936 | 19,974 | 308,275 | 307.3 K to 308.3 K (+0.30 %) |
| Oct 05 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 21.34 | 936 | 19,974 | 11,248,714 | 11.2 M to 11.2 M (+0.01 %) |
| Oct 05 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 21.34 | 936 | 19,974 | 1,737,837 | 1.7 M to 1.7 M (+0.05 %) |
| Oct 05 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 21.34 | 936 | 19,974 | 21,667 | 20.7 K to 21.7 K (+4.51 %) |
| Oct 05 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 21.34 | 936 | 19,974 | 182,326 | 181.4 K to 182.3 K (+0.52 %) |
| Oct 05 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 21.34 | 936 | 19,974 | 202,590 | 201.7 K to 202.6 K (+0.46 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.44 | 346,000 | 16,761,728 | 32,164,870 | 31.8 M to 32.2 M (+1.09 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 47.40 | 50,000 | 2,370,000 | 31,818,870 | 31.8 M to 31.8 M (+0.16 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 48.60 | 160,453 | 7,798,690 | 31,768,870 | 31.6 M to 31.8 M (+0.51 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 47.98 | 33,320 | 1,598,614 | 31,608,417 | 31.6 M to 31.6 M (+0.11 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 47.54 | 14,386 | 683,847 | 31,575,097 | 31.6 M to 31.6 M (+0.05 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 47.24 | 1,600 | 75,577 | 31,560,711 | 31.6 M to 31.6 M (+0.01 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 46.31 | 20,500 | 949,351 | 31,559,111 | 31.5 M to 31.6 M (+0.06 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 44.68 | 1,950 | 87,130 | 31,538,611 | 31.5 M to 31.5 M (+0.01 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 45.28 | 89,843 | 4,067,696 | 31,536,661 | 31.4 M to 31.5 M (+0.29 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 46.81 | 212,983 | 9,969,500 | 31,446,818 | 31.2 M to 31.4 M (+0.68 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 46.74 | 9,818 | 458,905 | 31,233,835 | 31.2 M to 31.2 M (+0.03 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 45.63 | 2,331 | 106,368 | 31,224,017 | 31.2 M to 31.2 M (+0.01 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 45.43 | 3,513 | 159,601 | 31,221,686 | 31.2 M to 31.2 M (+0.01 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 45.00 | 13,897 | 625,359 | 31,218,173 | 31.2 M to 31.2 M (+0.04 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 42.14 | 40,649 | 1,713,148 | 31,204,276 | 31.2 M to 31.2 M (+0.13 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 44.40 | 8,063 | 357,971 | 31,163,627 | 31.2 M to 31.2 M (+0.03 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 40.67 | 15,391 | 625,950 | 31,155,564 | 31.1 M to 31.2 M (+0.05 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 41.06 | 191,321 | 7,856,214 | 31,140,173 | 30.9 M to 31.1 M (+0.62 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 42.44 | 88,640 | 3,761,802 | 30,948,852 | 30.9 M to 30.9 M (+0.29 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 43.28 | 183,073 | 7,923,253 | 30,860,212 | 30.7 M to 30.9 M (+0.60 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 44.63 | 274,814 | 12,265,553 | 30,677,139 | 30.4 M to 30.7 M (+0.90 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 40.55 | 3,100 | 125,706 | 30,402,325 | 30.4 M to 30.4 M (+0.01 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 41.13 | 11,300 | 464,823 | 30,399,225 | 30.4 M to 30.4 M (+0.04 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 43.60 | 43,612 | 1,901,322 | 30,387,925 | 30.3 M to 30.4 M (+0.14 %) |
| Sep 15 2015 | SGEN | SEATTLE GENETICS I ... | BAKER FELIX | Director | Buy | P | 41.00 | 3,338,927 | 136,896,007 | 30,344,313 | 27 M to 30.3 M (+12.36 %) |
| Jul 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Option Exercise | A | 206.16 | 2,329 | 480,147 | 2,329 | |
| Jul 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 696 | 0 | 6,103,727 | 6.1 M to 6.1 M (+0.01 %) |
| Jul 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 696 | 0 | 506,861 | 506.2 K to 506.9 K (+0.14 %) |
| Jul 06 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 27.34 | 730 | 19,958 | 307,339 | 306.6 K to 307.3 K (+0.24 %) |
| Jul 06 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 27.34 | 730 | 19,958 | 11,247,778 | 11.2 M to 11.2 M (+0.01 %) |
| Jul 06 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 27.34 | 730 | 19,958 | 1,736,901 | 1.7 M to 1.7 M (+0.04 %) |
| Jul 06 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 27.34 | 730 | 19,958 | 20,731 | 20 K to 20.7 K (+3.65 %) |
| Jul 06 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 27.34 | 730 | 19,958 | 181,390 | 180.7 K to 181.4 K (+0.40 %) |
| Jul 06 2015 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 27.34 | 730 | 19,958 | 201,654 | 200.9 K to 201.7 K (+0.36 %) |
| Jun 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 6,103,033 | 0 | 6,103,033 | 0 to 6.1 M |
| Jun 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 506,166 | 0 | 506,166 | 0 to 506.2 K |
| Jun 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 94,412 | 0 | 94,412 | 0 to 94.4 K |
| Jun 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 66,154 | 0 | 66,154 | 0 to 66.2 K |
| Jun 24 2015 | ALXN | ALEXION PHARMACEUT ... | BAKER FELIX | Director | Grant | A | 0.00 | 65,811 | 0 | 65,811 | 0 to 65.8 K |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 23.00 | 15,000 | 345,000 | 0 | ||
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 40.74 | 7,500 | 305,550 | 0 | ||
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 40.32 | 7,500 | 302,400 | 0 |